Lung Cancer Immunotherapy: Improving Patient Outcomes Across the Disease Continuum

Download this slideset from a live CCO symposium for an overview of the key data on immunotherapy options for patients with early-stage resectable and stage III unresectable NSCLC.

Zofia Piotrowska, MD, MHS Released: November 10, 2022

Download this slideset from a live CCO symposium with key data on the changing landscape for the use of immunotherapy in advanced or metastatic NSCLC.

Julie R. Brahmer, MD
Program Director Released: November 10, 2022

Download this slideset from a live CCO symposium for expert perspective on optimal use of immunotherapy in various patient populations, including those with CNS metastases or poor performance status, along with highlights of emerging data on immunotherapy combination regimens in clinical trials.

Jarushka Naidoo, MB BCH BAO, MHS Released: November 10, 2022

Watch this on-demand webcast from a live satellite symposium on the use of immunotherapy for patients with lung cancer, including considerations in early-stage disease and treatment options for those with advanced NSCLC.

Julie R. Brahmer, MD
Program Director Jarushka Naidoo, MB BCH BAO, MHS Zofia Piotrowska, MD, MHS Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: January 17, 2023 Expired: No longer available for credit

Gain expert insights on best practices for incorporating immune checkpoint inhibitor therapy for patients with NSCLC.

Julie R. Brahmer, MD
Program Director Jarushka Naidoo, MB BCH BAO, MHS Zofia Piotrowska, MD, MHS Released: January 23, 2023